COMMUNIQUÉS West-GlobeNewswire
-
Ultragenyx Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Update
12/02/2026 -
Cytokinetics to Announce Fourth Quarter Results on February 24, 2026
12/02/2026 -
Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026
12/02/2026 -
Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026
12/02/2026 -
Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies
12/02/2026 -
Coherus Oncology, Inc. Announces Proposed Public Offering of Common Stock
12/02/2026 -
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2025 Results Report
12/02/2026 -
OKYO Pharma Announces Public Offering of Ordinary Shares
12/02/2026 -
NervGen Pharma Announces Retirement of Chief Financial Officer, Bill Adams
12/02/2026 -
Serotonin Centers Opens Naperville Location at Block 59, Marking Brand’s Entry into the Chicago Market
12/02/2026 -
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
12/02/2026 -
Globus Medical Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
12/02/2026 -
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
12/02/2026 -
BBOT to Participate in Upcoming Investor Healthcare Conferences
12/02/2026 -
Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th – Conference Call to Follow
12/02/2026 -
Pacira to Report 2025 Financial Results on Thursday February 26, 2026
12/02/2026 -
FDA Approves Labeling Changes to Menopausal Hormone Therapy Products
12/02/2026 -
FDA Approves First-of-Its-Kind Device to Treat Pancreatic Cancer
12/02/2026 -
La Croix-Rouge canadienne recueille des dons pour venir en aide aux personnes éprouvées par la tragédie à Tumbler Ridge, en Colombie-Britannique
12/02/2026
Pages